Thursday, 25 July 2013

CDRH Transparency Update

You are subscribed to CDRH Transparency for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

Evalution of Automatic Class III Designation (De Novo) Summaries

  • Cabochon System - K101231

CDRH Transparency home page  


This email was sent to buzzhairs.health@blogger.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

No comments:

Post a Comment